Key result
High thromboxane plus poor cardiovascular health linked to ~2.7-fold higher incident CVD risk.
Cohort (n=2,655)
Favorable lifestyle factors (measured by Life's Essential 8) and higher omega-3 fatty acids correlate with lower systemic thromboxane A2 generation, and a favorable cardiovascular health profile may attenuate the increased CVD and heart failure risks associated with high thromboxane production.
Answers are grounded in this paper and cite their sources.
High thromboxane with low LE8 signals elevated CVD risk; hypothesis-generating and requires prospective confirmation before clinical use.
BACKGROUND: Systemic thromboxane A2 generation, assessed via measurement of its urinary metabolites, is associated with cardiovascular disease (CVD) risk. Modifiable correlates with thromboxane A2 generation, including potentially nonplatelet sources not readily affected by aspirin, are poorly understood. METHODS: We investigated 2655 FHS (Framingham Heart Study) participants with measurements of urinary thromboxane B2 metabolites normalized for renal function (TXB2-MGFR). Life's Essential 8 (LE8) score was constructed from 8 modifiable factors. We additionally examined erythrocyte omega-3 fatty acids and omega-6 fatty acid levels, namely, eicosapentaenoic acid, docosahexaenoic acid, and arachidonic acid. In a subset of participants, objective measurements of vascular stiffness and adiposity were obtained. We related these factors to TXB2-MGFR using linear models, adjusting for age, sex, and aspirin use. We also explored the association of LE8 or omega-3 fatty acids with total CVD or heart failure stratified by TXB2-MGFR. RESULTS: Both total LE8 score (P<0.001) and individual LE8 components (P<0.05 for each), including favorable diet, physical activity, blood glucose, blood pressure, and nonsmoking, were associated with lower TXB2-MGFR. Higher omega-3 fatty acids (eicosapentaenoic acid+docosahexaenoic acid) and lower arachidonic acid were associated with lower TXB2-MGFR (P<0.005 for each). Higher TXB2-MGFR was related to greater waist circumference, computed tomography-measured visceral adipose tissue, and hepatic steatosis (P<0.01 for each), and higher large artery vascular stiffness (P<0.001). Findings were generally consistent across aspirin use status. After median follow-up of 12.9 years (371 CVD and 214 heart failure events), individuals with both high TXB2-MGFR and low LE8 displayed an over 5-fold higher risk of heart failure (hazard ratio, 5.07 [95% CI, 3.26-7.89]) and 2.5-fold higher risk of CVD (hazard ratio, 2.74 [95% CI, 2.04-3.68]) compared with participants with low TXB2-MGFR and high LE8. CONCLUSIONS: Our findings suggest several modifiable factors that may impact systemic thromboxane A2 generation. Higher systemic thromboxane A2 generation also appears to modulate the association of lifestyle measures (as assessed by LE8 score) with CVD and heart failure.
No takes yet. Share an insight, caveat, or question.
Qian et al. (2026) conducted a cohort in Cardiovascular Disease and Heart Failure Risk (n=2,655). High TXB2-MGFR and low Life's Essential 8 (LE8) score vs. Low TXB2-MGFR and high LE8 score was evaluated on Incident cardiovascular disease (HR 2.74, 95% CI 2.04-3.68). Individuals with high systemic thromboxane A2 generation and low Life's Essential 8 scores had a 2.74-fold increased risk of incident cardiovascular disease compared with participants with low thromboxane and high scores.
Synapse has enriched 10 related papers. Consider them for comparative context: